Bank of New York Mellon’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-160,161
Closed -$1.45M 4312
2024
Q1
$1.45M Sell
160,161
-9,391
-6% -$84.9K ﹤0.01% 2945
2023
Q4
$1.84M Buy
169,552
+6,148
+4% +$66.8K ﹤0.01% 2872
2023
Q3
$1.32M Sell
163,404
-366
-0.2% -$2.95K ﹤0.01% 3019
2023
Q2
$1.78M Buy
163,770
+111,757
+215% +$1.21M ﹤0.01% 2905
2023
Q1
$359K Buy
52,013
+32,896
+172% +$227K ﹤0.01% 3663
2022
Q4
$76.1K Sell
19,117
-365
-2% -$1.45K ﹤0.01% 4168
2022
Q3
$130K Sell
19,482
-780
-4% -$5.21K ﹤0.01% 4147
2022
Q2
$98K Sell
20,262
-99,943
-83% -$483K ﹤0.01% 4225
2022
Q1
$1.12M Sell
120,205
-331
-0.3% -$3.1K ﹤0.01% 3237
2021
Q4
$1.43M Buy
120,536
+1,639
+1% +$19.5K ﹤0.01% 3178
2021
Q3
$1.35M Buy
118,897
+16,270
+16% +$185K ﹤0.01% 3226
2021
Q2
$1.84M Buy
102,627
+7,172
+8% +$129K ﹤0.01% 3032
2021
Q1
$1.48M Buy
95,455
+7,158
+8% +$111K ﹤0.01% 3100
2020
Q4
$1.08M Buy
88,297
+23,077
+35% +$281K ﹤0.01% 3217
2020
Q3
$838K Buy
65,220
+3,534
+6% +$45.4K ﹤0.01% 3221
2020
Q2
$627K Buy
61,686
+2,209
+4% +$22.5K ﹤0.01% 3363
2020
Q1
$483K Buy
59,477
+26,879
+82% +$218K ﹤0.01% 3382
2019
Q4
$282K Hold
32,598
﹤0.01% 3823
2019
Q3
$201K Sell
32,598
-1,667
-5% -$10.3K ﹤0.01% 3898
2019
Q2
$569K Sell
34,265
-1,902
-5% -$31.6K ﹤0.01% 3533
2019
Q1
$605K Buy
36,167
+9,844
+37% +$165K ﹤0.01% 3458
2018
Q4
$302K Sell
26,323
-1,297
-5% -$14.9K ﹤0.01% 3704
2018
Q3
$1.11M Buy
27,620
+980
+4% +$39.2K ﹤0.01% 3207
2018
Q2
$754K Buy
26,640
+17,466
+190% +$494K ﹤0.01% 3400
2018
Q1
$140K Buy
9,174
+872
+11% +$13.3K ﹤0.01% 3988
2017
Q4
$271K Buy
8,302
+2,841
+52% +$92.7K ﹤0.01% 3829
2017
Q3
$128K Buy
+5,461
New +$128K ﹤0.01% 3964
2017
Q2
Sell
-5,057
Closed -$36K 4355
2017
Q1
$36K Buy
+5,057
New +$36K ﹤0.01% 4173
2016
Q3
Sell
-4,119
Closed -$21K 4319
2016
Q2
$21K Sell
4,119
-15
-0.4% -$76 ﹤0.01% 4261
2016
Q1
$89K Buy
+4,134
New +$89K ﹤0.01% 3981